Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Carl Shanholtz"'
Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure
Autor:
Li Gao, Nicholas Rafaels, Tanda M. Dudenkov, Mahendra Damarla, Rachel Damico, James P. Maloney, Marc Moss, Greg S. Martin, Jonathan Sevransky, Carl Shanholtz, Dan L. Herr, Joe G.N. Garcia, Tamara Hernandez-Beeftink, Jesús Villar, Carlos Flores, Terri H. Beaty, Roy Brower, Paul M. Hassoun, Kathleen C. Barnes
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Sepsis and associated organ failures confer substantial morbidity and mortality. Xanthine oxidoreductase (XOR) is implicated in the development of tissue oxidative damage in a wide variety of respiratory and cardiovascular disorde
Externí odkaz:
https://doaj.org/article/03c6fd5c4e4d4efd835394c679a13f8b
Autor:
Djordje Atanackovic, Stephanie V. Avila, Forat Lutfi, Diego de Miguel-Perez, Xiaoxuan Fan, Gabriela Sanchez-Petitto, Erica Vander Mause, Jonathan Siglin, John Baddley, Heather D. Mannuel, Hanan Alkhaldi, Kim G. Hankey, Rena Lapidus, Michael Kleinberg, Joseph Rabin, Carl Shanholtz, Christian Rolfo, Aaron P. Rapoport, Saurabh Dahiya, Tim Luetkens
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
Atanackovic and coauthors screen COVID-19 patients for antibodies against 9 different SARS-CoV-2 proteins observing responses against the spike (S) proteins, the receptor-binding domain (RBD), and the nucleocapsid (N) protein which were of the IgG1 a
Externí odkaz:
https://doaj.org/article/fb56e5486aff47208a34a57aea2883cd
Autor:
Wesley H. Self, Thomas G. Stewart, Allison P. Wheeler, Wissam El Atrouni, Amanda J. Bistran-Hall, Jonathan D. Casey, Vince D. Cataldo, James D. Chappell, Claudia S. Cohn, Jessica B. Collins, Mark R. Denison, Marjolein de Wit, Sheri L. Dixon, Abhijit Duggal, Terri L. Edwards, Magali J. Fontaine, Adit A. Ginde, Michelle S. Harkins, Thelma Harrington, Estelle S. Harris, Daanish Hoda, Tina S. Ipe, Stuti J. Jaiswal, Nicholas J. Johnson, Alan E. Jones, Maryrose Laguio-Vila, Christopher J. Lindsell, Jason Mallada, Manoj J. Mammen, Ryan A. Metcalf, Elizabeth A. Middleton, Simon Mucha, Hollis R. O’Neal, Sonal R. Pannu, Jill M. Pulley, Xian Qiao, Jay S. Raval, Jillian P. Rhoads, Harry Schrager, Carl Shanholtz, Nathan I. Shapiro, Stephen J. Schrantz, Isaac Thomsen, Krista K. Vermillion, Gordon R. Bernard, Todd W. Rice, For the Passive Immunity Trial for Our Nation (PassITON) Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. Methods The Passive Immunity Trial for Our Nation (PassITO
Externí odkaz:
https://doaj.org/article/09f00f69e5d142a1b19dcc01b4acebd6
Autor:
Wesley H. Self, Allison P. Wheeler, Thomas G. Stewart, Harry Schrager, Jason Mallada, Christopher B. Thomas, Vince D. Cataldo, Hollis R. O’Neal, Nathan I. Shapiro, Conor Higgins, Adit A. Ginde, Lakshmi Chauhan, Nicholas J. Johnson, Daniel J. Henning, Stuti J. Jaiswal, Manoj J. Mammen, Estelle S. Harris, Sonal R. Pannu, Maryrose Laguio-Vila, Wissam El Atrouni, Marjolein de Wit, Daanish Hoda, Claudia S. Cohn, Carla McWilliams, Carl Shanholtz, Alan E. Jones, Jay S. Raval, Simon Mucha, Tina S. Ipe, Xian Qiao, Stephen J. Schrantz, Aarthi Shenoy, Richard D. Fremont, Eric J. Brady, Robert H. Carnahan, James D. Chappell, James E. Crowe, Mark R. Denison, Pavlo Gilchuk, Laura J. Stevens, Rachel E. Sutton, Isaac Thomsen, Sandra M. Yoder, Amanda J. Bistran-Hall, Jonathan D. Casey, Christopher J. Lindsell, Li Wang, Jill M. Pulley, Jillian P. Rhoads, Gordon R. Bernard, Todd W. Rice
Publikováno v:
Chest. 162:982-994
Autor:
Carl Shanholtz
Publikováno v:
Critical Care Medicine. 51:686-688
Autor:
Rafael S Cires-Drouet, Jacob Sama, Paul Han, Kevin Jones, Daniel Haase, Taylor Miller, Shahab Toursavadkohi, Khanjan Nagarsheth, Lateaqua Alston, Angela Smedley, Carl Shanholtz, Minerva Mayorga-Carlin, John D Sorkin, Susie N Hong, Gautam Ramani, Bartley Griffith, Brajesh K Lal, Bradley Taylor
Publikováno v:
Phlebology: The Journal of Venous Disease. 37:678-685
Background Despite socioeconomic disparities, no association between clinical presentation and poor outcomes explains a higher mortality in African Americans with pulmonary embolism (PE). The objective is to identify the co-morbidities and echocardio
Autor:
Cheryl Dennison Himmelfarb, Victor D. Dinglas, Alison E. Turnbull, Hongkai Ji, Pedro A. Mendez-Tellez, Ramona O. Hopkins, Megan M. Hosey, Albert W. Wu, Dale M. Needham, Carl Shanholtz
Publikováno v:
Chest. 161:407-417
Background Perceived health is one of the strongest determinants of subjective well-being, but it has received little attention among survivors of ARDS. Research question How well do self-reported measures of physical, emotional, and social functioni
Autor:
Lyndsay M. O’Hara, Carl Shanholtz, Michael J Armahizer, Surbhi Leekha, Jessica P. Brown, Blaine Kenaa, Mary Richert
Publikováno v:
Infection Control & Hospital Epidemiology. 43:284-290
Background:Prompt diagnosis and intervention for ventilator-associated pneumonia (VAP) is critical but can lead to overdiagnosis and overtreatment.Objectives:We investigated healthcare provider (HCP) perceptions and challenges associated with VAP dia
Autor:
Jean A. Yared, Elizabeth Hutnick, Ashraf Badros, Mehmet H. Kocoglu, Nancy M. Hardy, Forat Lutfi, Søren M. Bentzen, Jonathan Siglin, Aaron P. Rapoport, Firas El Chaer, Carl Shanholtz, Kathleen Ruehle, Vivek Kesari, Noa G. Holtzman, Hao Xie, Haroon Ahmad, Saurabh Dahiya, Ali Bukhari, Natalie Gahres
Publikováno v:
Neuro Oncol
Background CD19-directed chimeric antigen receptor (CAR) T-cell therapy (CAR-T) has emerged as effective for relapsed/refractory large B-cell lymphoma (R/R LBCL). The neurologic toxicity seen with CAR-T, referred to as immune effector cell–associat
Autor:
Matthew A. Warner, Daryl J. Kor, Ryan D. Frank, Cheryl Dennison Himmelfarb, Victor D. Dinglas, Curtis B. Storlie, Dale M. Needham, Pedro A. Mendez-Tellez, Carl Shanholtz
Publikováno v:
Journal of Intensive Care Medicine. 36:557-565
Objective: Anemia is common during critical illness and often persists after hospital discharge; however, its potential association with physical outcomes after critical illness is unclear. Our objective was to assess the associations between hemoglo